Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.35
-0.09 (-1.65%)
At close: Aug 26, 2026, 4:00 PM EDT
5.35
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:04 PM EDT
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 533 employees as of December 31, 2025. The number of employees increased by 165 or 44.84% compared to the previous year.
Employees
533
Change (1Y)
165
Growth (1Y)
44.84%
Revenue / Employee
$404,730
Profits / Employee
-$515,672
Market Cap
323.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 533 | 165 | 44.84% |
| Dec 31, 2024 | 368 | 165 | 81.28% |
| Dec 31, 2023 | 203 | -87 | -30.00% |
| Dec 31, 2022 | 290 | 12 | 4.32% |
| Dec 31, 2021 | 278 | -14 | -4.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Fate Therapeutics | 161 |
| Orchestra BioMed Holdings | 86 |
| SAB Biotherapeutics | 86 |
| Cartesian Therapeutics | 75 |
| Immuneering | 57 |
| Vicore Pharma Holding AB | 40 |
VNDA News
- 2 days ago - Vanda awarded Orphan Designation in Europe for treatment of GPP - TheFly
- 2 days ago - Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission - PRNewsWire
- 4 days ago - NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. - PRNewsWire
- 16 days ago - Vanda Pharmaceuticals price target lowered to $12 from $17 at B. Riley - TheFly
- 16 days ago - Vanda Pharmaceuticals price target lowered to $20 from $21 at H.C. Wainwright - TheFly
- 20 days ago - Vanda Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 20 days ago - Vanda Pharmaceuticals Earnings release: Q2 2026 - Filings
- 20 days ago - Vanda Pharmaceuticals Quarterly report: Q2 2026 - Filings